DVL3 and breast cancer: DVL3 is expressed in BC cells and is upregulated by oncogene c-Myc and cyclin D. Overexpression of DVL3 upregulates β-catenin and, thus, induces Wnt/β-catenin pathway which induces in vitro cell proliferation in BC cells.